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Abstract
The cardiovascular system is the first functional organ in the embryo, and its blood 
vessels form a widespread conductive network within the organism. Blood vessels 
develop de novo, by the differentiation of endothelial progenitor cells (vasculogen-
esis) or by angiogenesis, which is the formation of new blood vessels from existing 
ones. This review presents an overview of the current knowledge on physiological 
and pathological angiogenesis in the horse including studies on equine endothelial 
cells. Principal study fields in equine angiogenesis research were identified: equine 
endothelial progenitor cells; equine endothelial cells and angiogenesis (heterogeneity, 
markers and assessment); endothelial regulatory molecules in equine angiogenesis; 
angiogenesis research in equine reproduction (ovary, uterus, placenta and conceptus, 
testis); angiogenesis research in pathological conditions (tumours, ocular patholo-
gies, equine wound healing, musculoskeletal system and laminitis). The review also 
includes a table that summarizes in vitro studies on equine endothelial cells, either 
describing the isolation procedure or using previously isolated endothelial cells. A 
particular challenge of the review was that results published are fragmentary and 
sometimes even contradictory, raising more questions than they answer. In conclu-
sion, angiogenesis is a major factor in several diseases frequently occurring in horses, 
but relatively few studies focus on angiogenesis in the horse. The challenge for the 
future is therefore to continue exploring new therapeutic angiogenesis strategies for 
horses to fill in the missing pieces of the puzzle.
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1  | INTRODUC TION
Blood vessels transport vital oxygen and nutrients through the 
body, remove metabolic waste products and facilitate communica-
tion between tissues and organs via the blood stream. Development, 
maintenance and remodelling of the circulatory system in health and 
disease require a plethora of regulatory mechanisms. The growth of 
blood vessels, for example in response to tissue hypoxia, is in gen-
eral often referred to as angiogenesis. In sensu stricto, angiogenesis 
is defined as the formation of new vessels from pre-existing ones. 
The term “neovascularization” is used for different types of vessel 
formation, that is, vasculogenesis, angiogenesis as well as arterio- 
and venogenesis. Here, the prefix “neo” (from ancient Greek νέος 
néos “new,” “fresh,” “young”) emphasizes the new development 
of blood vessels. The term “neoangiogenesis” is often applied to 
pathological angiogenesis in tumours and other diseases (Chopra, 
Hung, Kwong, Zhang, & Pow, 2018; Ribatti, Vacca, Nico, Roncali, & 
Dammacco, 2001; Sharma, Sharma, & Sarkar, 2005; Simons, 2005).
The cardiovascular system is the first functional organ in the em-
bryo, and its blood vessels form a widespread conductive network 
within the organism. Blood vessels develop de novo (Figure 1a) in 
the embryo but also in the postnatal period and the adult through 
differentiation from mesoderm-derived endothelial precursor cells. 
This process is termed vasculogenesis or de novo vascularization 
and, depending on the location and size of the vessel, results in a 
multicellular tube, comprising endothelial cells, smooth muscle cells, 
pericytes (or mural cells) and basement membrane components 
(Emanueli, Schratzberger, Kirchmair, & Madeddu, 2003; Potente & 
Carmeliet, 2017; Risau, 1997; Tang & Conti, 2004).
Angiogenesis expands existing vessel networks via sprouting or 
splitting (Figure 1b). Sprouting angiogenesis in vivo takes place in 
several successive stages or steps, the angiogenic cascade. Briefly, 
angiogenic stimuli cause increased endothelial cell permeability, in-
vasiveness and proliferation; basement membrane components are 
proteolysed to facilitate invasion of endothelial cells into the stroma 
of the neighbouring tissue; lumen formation occurs, as the sprout 
forms a multicellular structure and meets up with an adjacent sprout; 
the new capillary is stabilized with a basement membrane and peri-
cytes are recruited (Potente & Carmeliet, 2017; Yoo & Kwon, 2013). 
The angiogenic cascade of endothelial cells in vitro has been classi-
fied and quantified for several species, including the horse (Dietze 
et al., 2014). In splitting or intussusceptive angiogenesis, a single ves-
sel is split in two. This type of angiogenesis requires reorganization 
of resident endothelial cells and is not based on immediate prolifer-
ation or migration of the endothelium (Adair & Montani, 2010; De 
Spiegelaere et al., 2012).
Arterio- and venogenesis are the result of modification and 
expansion of existing arteries and veins (Nagy & Dvorak, 2012). 
Interestingly, little information is available on venogenesis and the 
transformation of collateral vessels (collateralization, the develop-
ment of an alternate circulation around a blocked artery or vein) 
after thrombosis, although many diseases such as thrombosis are 
associated with the venous system (Palmer, Braybrooks, Cao, Diaz, 
& Greve, 2019).
The cells that line the lumen of blood vessels—the endothelial 
cells—are a highly heterogeneous population. While endothelial cells 
are usually quiescent as "phalanx" cells throughout adult life, they 
can quickly become highly active migratory "tip" cells or prolifera-
tive "stalk" cells and sprout into avascular tissue to form new blood 
vessels (Zecchin, Kalucka, Dubois, & Carmeliet, 2017). Since the 
change from quiescence to growth during angiogenesis is metabol-
ically demanding, not only the coordination of the morphogenetic 
behaviour, but also an adjustment of the metabolic activities is nec-
essary (Potente & Carmeliet, 2017).
These processes must be tightly regulated, and dysregulated 
angiogenesis as well as endothelial dysfunction has severe conse-
quences for the system. Endothelial dysfunction leads to a decrease 
in the bioavailability of vasodilators, in particular nitric oxide (NO), 
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F I G U R E  1   Vasculogenesis and angiogenesis. (a) Vasculogenesis is the differentiation of endothelial progenitor cells and their formation 
into a simple blood capillary network; (b) Angiogenesis is the formation of new vessels from existing ones. There are two mechanisms of 
angiogenesis: sprouting (arrowhead) and intussusception (arrow). Published in: Kassmeyer, Plendl, Custodis, and Bahramsoltani (2009). New 
insights in vascular development: vasculogenesis and endothelial progenitor cells. Anat Histol Embryol 38(1): 1–11
(a) (b)
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and/ or to an increase in contraction factors derived from the endo-
thelium, which leads to an impairment of endothelium-dependent 
vasodilation. Another aspect of endothelial dysfunction can be en-
dothelial activation, which is characterized by an inflammatory, pro-
liferative and procoagulant state favouring atherogenesis and the 
induction of aberrant angiogenesis (Hadi, Carr, & Al Suwaidi, 2005; 
Rajashekhar et al., 2006). Numerous forms of cardiovascular dis-
ease are associated with endothelial dysfunction. Free radicals 
can disrupt the NO balance, damage the endothelium and make it 
excessively permeable so that toxins can get into the body tissues 
(Rajendran et al., 2013). Dysregulated angiogenesis contributes to 
impaired wound healing, ocular pathologies, problems of the muscu-
loskeletal system, laminitis and many forms of cancer. Angiogenesis 
and its inhibition, anti-angiogenesis, are principal factors in these 
diseases that frequently occur in horses. Taken into account that 
the regulation of angiogenesis in horses is, at least to some extent, 
horse-specific (Morgan et al., 2018), it is crucial to understand more 
about angiogenesis in equidae.
In order to increase our knowledge on equine angiogenesis, and 
to work towards new dependable therapeutic pro- and anti-angio-
genic strategies for horses, we undertook this review. It provides 
an overview on the current knowledge on equine angiogenesis and 
endothelial cells in both physiological and pathological conditions. 
Compared to the vast amount of research in many other species, 
relatively few studies focus on equine angiogenesis and only a small 
number of research groups worldwide focuses on species-specific 
research of equine endothelial cells, the most important cells in 
angiogenesis.
To identify topics in equine angiogenesis research for this review, 
the software VOSviewer was used to produce a graphical abstract 
(Figure 2). Therefore, in May 2019, “web of science” was searched 
for the terms “angiogen*” AND “horse OR equine OR mare OR stal-
lion” in “topic”. No search limitations for the range of years were ap-
plied. Web of science was chosen due to the availability of author 
key words in the metadata, from which the graphical abstract was 
compiled. Out of the resulting 260 publications, approximately 50% 
were used for the graphical abstract and included research on/ for 
the horse, research with cells from the horse, reviews in which the 
term “horse” was found or at least studies referring to the horse. 
The other publications were not included in this manuscript, be-
cause they were only peripherally related to the horse, meaning 
that in the broadest sense, materials or viruses relating to the horse 
were used (e.g. equine chorionic gonadotropin or equine infectious 
anaemia virus). Publications that had nothing to do with horses but 
included the term “horse” in words like horse chestnut, horse mint, 
Trojan horse or horse-radish peroxidase, were excluded, too. The re-
maining 139 publications were used to create the graphical abstract 
with the author key words. The graphic was created with VOSviewer 
F I G U R E  2   Principal study fields in equine research associated with angiogenesis. The graphic shows an author key word analysis 
for literature sources referring to angiogenesis in horses. A full version of this figure can be opened with the freely available VOSviewer 
software (Centre for Science and Technology Studies, Leiden University, Leiden, The Netherlands), using the supplementary files
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software version 1.6.10 (Centre for Science and Technology Studies, 
Leiden University, Leiden, The Netherlands; http://www.vosvi ewer.
com; Copyright (c) 2009–2019 Nees Jan van Eck and Ludo Waltman) 
according to instructions of the supplier. A thesaurus file was used 
to delete general terms (like animals or tissue), merge matching terms 
(like tumour and cancer) and delete terms plausibly present but not 
necessary (like horse or angiogenesis). From the plethora of principal 
study fields identified in equine angiogenesis research (Figure 2), we 
picked the ones presented in this review. We had to skip several top-
ics and were only able to briefly address a few others. We encour-
age the interested reader to take a closer look at Figure 2, using the 
Data S1 and S2, if other topics of angiogenesis research in the horse 
are of interest. Other databases such as Medline or PubMed were 
additionally used for the actual review and the search terms were 
adapted to the respective topics.
2  | EQUINE ENDOTHELIAL PROGENITOR 
CELL S
Until the 1990s, it was assumed in mammals that new blood ves-
sels were mainly formed prenatally by vasculogenesis of endothelial 
progenitor cells and that new vessels only grew out of existing ves-
sels postnatally, via angiogenesis. Today, there is a consensus that 
endothelial progenitor cells play a significant role not only prenatally 
but also in the adult in the formation of blood vessels, both in the 
course of regenerative and pathological processes such as tumour 
growth (Shi et al., 2017; Wang et al., 2010). Especially, in regenera-
tive medicine, endothelial progenitor cells have gained great im-
portance due to their ability to regenerate and revasculate tissues, 
for example ischaemic tissues, as well as due to their potential for 
the vascularization of engineered tissues, for example reviewed by 
Chong, Ng, and Chan (2016); Hristov, Erl, and Weber (2003); Peters 
(2018).
In recent years, it has become increasingly clear that the effec-
tiveness of cell-based tissue regeneration and tissue engineering 
therapy approaches depends on the vascularization of these newly 
formed tissues. Without the establishment of a new vascular bed, 
their regeneration potential remains poor, because of the lack of 
nutrients and oxygen (Tasev, Koolwijk, & van Hinsbergh, 2016). 
Consequently, endothelial progenitors are used for the therapy of 
equine diseases associated with ischaemia or to enhance vascular-
ization within tissue-engineered models or cell-based therapeutic 
concepts (Koch, Berg, & Betts, 2009; Winter et al., 2018).
Within veterinary medicine, equine medicine is at the fore-
front when it comes to innovative cell-based therapies to regener-
ate or replace damaged tissues. Beginning around the year 2000, 
stem cell-based therapies for horses have been used for diseases 
of the musculoskeletal system affecting tendons, ligaments, artic-
ular cartilage and bone (Barboni et al., 2018). Equine mesenchymal 
stem cells (MSC), derived from bone marrow or fatty tissue, are 
mainly used for this purpose (Arnhold, Absenger, Klein, Addicks, & 
Schraermeyer, 2007; Arnhold, Elashry, Klymiuk, & Wenisch, 2019). 
MSC are ideal for tissue engineering and cell therapy for the mus-
culoskeletal structures because they can differentiate into different 
mesenchymal cell lines like for example chondrocytes or osteocytes 
and are easy to obtain (Bara, McCarthy, Humphrey, Johnson, & 
Roberts, 2014; Park et al., 2018).
Recently, endothelial colony forming cells (ECFC) have been 
characterized and described in the equine medical literature. ECFC 
are endothelial progenitor cells with robust proliferative and clonal 
abilities; therefore, they are also called outgrowth endothelial cells 
or “late” endothelial progenitor cells. These cells are useful candi-
dates in the initiation and facilitation of neovascularization (Banno 
& Yoder, 2018). In adult horses, they can be used therapeutically 
for diseases associated with ischaemia or delayed vascularization 
(Salter et al., 2015; Seeto et al., 2017; Sharpe et al., 2016; Winter 
et al., 2018). While in human medicine, ECFC are isolated primar-
ily from peripheral blood or from umbilical cord blood (Tasev 
et al., 2016), those used in equine medicine are usually isolated from 
the peripheral blood of horses that was collected from the jugular or 
the cephalic veins (Salter et al., 2015; Sharpe et al., 2016).
Research and application of ECFC in equine medicine are still 
in its early stages and the majority is basic and describes the isola-
tion and characterization of these cells. Recently, Seeto et al. (2017) 
studied the application of autologous ECFCs in equine wound heal-
ing. For this purpose, the cells were encapsulated into microspheres 
made from polyethylene glycol-fibrinogen hydrogel and injected lo-
cally into deep skin wounds of the horses distal limb, affecting all 
skin layers. First results showed that the injected ECFCs proliferated 
and migrated into the injured tissue. In addition, the ECFCs main-
tained their viability, proliferation and phenotype within the injured 
tissue (Seeto et al., 2017). In a follow-up study, the procedure was 
found to be well-tolerated and deemed practical for clinical applica-
tion. The treatment had positive effects on blood vessel density and 
wound inflammation (Winter et al., 2020).
3  | EQUINE ENDOTHELIAL CELL S AND 
ANGIOGENESIS (HETEROGENEIT Y, 
MARKERS AND A SSESSMENT )
In order to analyse angiogenesis in vivo or in vitro, it is essential to 
specifically identify the cells that perform angiogenesis, that is, en-
dothelial cells. However, there is no marker for all endothelial cells 
because, by nature, these cells are not a homogenous population 
but rather a heterogenous one. Endothelial cells form a single layer 
that lines the interior surfaces of all blood vessels and the heart. 
Endothelial cells are not a homogenous “wallpaper” of the circula-
tory system, but rather a highly heterogeneous cell population with 
distinct functions in different vessels and organs. Depending on the 
organ, capillary endothelium comes in continuous, fenestrated or 
discontinuous form. In addition, endothelial heterogeneity is linked 
to gene and antigen expression resulting in differences in morphol-
ogy and function. Beyond that, endothelial cells vary between dif-
ferent species, sexes, developmental stages and organs and even 
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neighbouring endothelial cells of the same organ and blood vessel 
may be different in antigen expression (Aird, 2007a, 2007b, 2012). 
For identification of the endothelial nature of cells, several different 
markers are available for the horse.
Amongst the first markers published for equine endothelial cells 
in situ were lectins, that is proteins or glycoproteins recognizing spe-
cific carbohydrates. Alroy, Goyal, and Skutelsky (1987) found endo-
thelial cells in tissue specimens of myocardium, uterus and adipose 
tissue from horses to be positive for the lectins Bandeiraea simplicifo-
lia agglutinin I, Ricinus communis agglutinin I, soybean agglutinin and 
wheat germ agglutinin. Moreover, the lectins Evonymus europaeus 
agglutinin and Cytisus sessilifolius agglutinin react with equine heart 
endothelium (Roussel & Dalion, 1988). In both aforementioned stud-
ies (Alroy et al., 1987; Roussel & Dalion, 1988) Ulex europaeus agglu-
tinin I was reported to be negative for equine endothelium. Contrary 
to this, Johnson, Miller, Floss, and Turk (1996) used positive labelling 
by Ulex europeus I to confirm the endothelial origin of vascular struc-
tures in benign vascular neoplasms (haemangiomas) of young horses.
For horses, as in many other species, immunohistochemical 
staining of the coagulation co-factor von Willebrand factor (vWF) 
(Figure 3) has been found to be a useful marker of endothelial cells 
(Bochsler, Slauson, Chandler, & Suyemoto, 1989; Bosch, Moleman, 
Barneveld, van Weeren, & van Schie, 2011; Chiam et al., 2006; Dietze 
et al., 2014; Johnson et al., 1996; MacEachern, Smith, & Nolan, 1997; 
Rieger et al., 2018; Rosenberg, Greengard, & Montgomery, 2000). 
The quantitative expression of this marker seems to vary in the 
horse. Benazzi, Torre, Sarli, and Marcheselli (2000), who used vWF 
to identify endothelial cells of blood vessels in the equine fetlock 
annular ligament, found strong capillary immunostaining, especially 
in cases with chronic inflammation.
Another in vitro marker used for endothelial cells in different spe-
cies including the horse is acetylated low-density lipoprotein (Ac-
LDL). Caution has to be taken in interpreting results as Ac-LDL is not 
only internalized and metabolized by endothelial but also by other 
cells like macrophages (Li, Hu, Jorgenson, & Slayton, 2009). Using 
DiI-Ac-LDL, equine endothelial cells have been labelled for example 
by Bochsler et al. (1989); Laval, Favoreel, Poelaert, Van Cleemput, 
and Nauwynck (2015); Wunn, Wardrop, Meyers, Kramer, and Ragle 
(1999).
An additional endothelial marker that works very well is CD31 
(Platelet endothelial cell adhesion molecule 1, PECAM1). Equine 
PECAM1 was cloned and sequenced by Gregg and Schenkel (2008), 
who describe it to be highly conserved amongst several species re-
sulting in a broad species cross-reactivity for the marker. This mol-
ecule, a transmembrane receptor that is expressed by endothelial 
and other cells, is involved in angiogenesis and was found to be 
up-regulated in samples of pregnant mare's endometrium (Merkl 
et al., 2010). PECAM1 also labels equine endothelium within gran-
ulation tissue during wound repair, where a high density of blood 
vessels was documented using immunostaining of this antigen 
(Miragliotta, Ipina, Lefebvre-Lavoie, Lussier, & Theoret, 2008; Wise 
et al., 2018).
In angiogenesis, capillary endothelial cells have the capability to 
make the first steps in angiogenesis, that is degradation of the basal 
membrane by matrix metalloproteinases (MMPs) and subsequent mi-
gration (Rundhaug, 2005). Accordingly, Ellenberger, Muller, Schoon, 
Wilsher, and Allen (2009) found heterogeneity in immunostaining 
for matrix metalloproteinase-2 in the equine ovary: only endothelial 
cells of capillaries but not of other vessel types were positive for this 
enzyme that degrades components of the extracellular matrix allow-
ing endothelial cells to migrate into the surrounding tissue.
Another striking example of endothelial heterogeneity is their 
morphological and functional heterogeneity observed during the an-
giogenesis cascade, where endothelial tip and stalk cells can be dis-
tinguished. The tip cells lead the new sprout, stalk cells migrate and 
proliferate behind them and build up the new sprout (Aird, 2012). Tip 
and stalk cells (Figure 4) were documented in equine endothelial cell 
cultures by Dietze et al. (2014) and Rieger et al. (2018). Tip cells are 
non-proliferative, display numerous filopodia (Gerhardt et al., 2003) 
and express CD 34 (Siemerink et al., 2012).
The assessment of proliferation, for example in stalk cells, is 
possible with Ki67, a marker of proliferating cells. It has been per-
formed successfully in equine endothelial cells by several groups 
(Al-zi'abil, Watson, & Fraser, 2003; Martano et al., 2018; Watson & 
F I G U R E  3   Von Willebrand factor and Weibel–Palade bodies in cultured equine arterial endothelial cells. (a) Immunohistochemical 
staining of von Willebrand factor (b) Transmission electron microscopic image of endothelial cells with Weibel–Palade bodies, the storage 
granules for the von Willebrand factor. Images are unpublished results from Rieger et al. (2018). Detailed methods of immunolabelling and 
electron microscopy are published in Dietze et al. (2014)
(a) (b)
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Ai-zi'abi, 2002). Moreover, Histone-3 has been shown to label equine 
endothelium at certain stages of mitosis (Hendzel et al., 1997).
The opposite of mitosis and cell proliferation, that is, programmed 
cell death (apoptosis), is also important in angiogenesis. The com-
plex development of a vascular network from a primitive endothelial 
sprout involves apoptotic death of endothelial cells during lumen 
formation and vascular remodelling (Lienau et al., 2005; Watson, 
Grant, & Coultas, 2017). Analysis of equine endothelial apoptosis 
can be successfully done via TUNEL test detecting DNA fragmen-
tation (Al-zi'abi, Fraser, & Watson, 2002) or via activated caspase-3, 
another marker for apoptosis (Aguilar et al., 2006).
It can be noted that there is no “marker of angiogenesis” but 
only markers of vascular endothelial cells. The search for markers 
of angiogenesis implies the identification of angiogenic and non-an-
giogenic endothelial cells. New technologies, including proteomics, 
are promising tools; however, so far, there is still a lack of reliable 
markers for the identification of angiogenic endothelial cells that 
perform all stages of the angiogenic cascade (Bahramsoltani, Harms, 
Drewes, & Plendl, 2013; Nowak-Sliwinska et al., 2018). For example, 
Matsuda, Hagio, and Ishiwata (2013) found that nestin, an interme-
diate filament protein, is an angiogenesis and tumour angiogenesis 
marker, but, the authors also state that, “nestin is expressed at the 
early stages of normal development, under pathological conditions, 
it is re-expressed in repair processes, various neoplasms and prolif-
erating vascular endothelial cells.”
For the assessment of angiogenesis, different assays are available 
(Bahramsoltani, Plendl, Janczyk, Custodis, & Kaessmeyer, 2009). 
The aortic ring model has been used to assess the effects of cortisol 
in equine vessels (Morgan et al., 2018). The development of capil-
lary-like structures was observed in isolated equine endothelial cells 
in vitro (Dietze et al., 2014). In vitro tubule formation on basement 
membrane matrix has been done on both equine endothelial progen-
itor cells (Salter et al., 2015; Seeto et al., 2017; Sharpe et al., 2016) 
and equine endothelial cells (Bussche & Van de Walle, 2014). A 
wound healing or scratch assay, an in vitro assay, has been used in 
horse endothelial cells (Rieger et al., 2018).
In order to study in vitro angiogenesis in the horse, equine endo-
thelial cells are needed for culture. Worldwide, there are relatively 
few laboratories isolating and/or working on equine endothelial 
cells. Table 1 lists in vitro studies that either describe the isolation 
procedure of equine endothelial cells or use endothelial cells that 
have previously been isolated from horses.
4  | ENDOTHELIAL REGUL ATORY 
MOLECULES IN EQUINE ANGIOGENESIS
Angiogenesis is regulated by a variety of soluble pro- and anti-angio-
genic growth factors (Schroder, 2019). The two most important ones 
are the vascular endothelial growth factors (VEGF) and the angiopoi-
etins (Ang) (Fagiani & Christofori, 2013; Melincovici et al., 2018). The 
regulatory role of these molecules in the horse will be pointed out in 
different chapters of this review, and therefore, they are only gener-
ally introduced in the following:
VEGF is known to trigger endothelial proliferation, migration 
and angiogenesis. As recently reviewed by Melincovici et al. (2018), 
the VEGF family includes VEGF-A, B, C, D, E, F, the placenta growth 
factor (PlGF) and the endocrine gland-derived vascular endothe-
lial growth factor. Bussche and Van de Walle (2014) examined the 
presence of angiogenic factors in conditioned medium of equine pe-
ripheral blood-derived MSC and examined their influence on equine 
endothelial cells. They confirmed that peripheral blood-derived MSC 
induce angiogenesis and that endothelial VEGF-A is important in 
autocrine and paracrine signalling in the horse (Bussche & Van de 
Walle, 2014).
VEGF binds to three receptors, that is, VEGFR-1, VEGFR-2 and 
VEGFR-3. VEGFR-1 (or Flt-1) and VEGFR-2 (also known as KDR 
or flk1) are primarily found on the vascular endothelium; in con-
trast, VEGFR-3 is found on lymphatic endothelium (Melincovici 
et al., 2018).
Angiopoietins (Ang1, Ang2, Ang3, Ang4) are secreted vascu-
lar growth factors required for vasculogenesis and angiogenesis. 
Tyrosine kinase receptor 1 and 2 (Tie1 and Tie2) are the cell surface 
receptors that bind the angiopoietins (Fagiani & Christofori, 2013).
Other molecules involved in angiogenesis and investigated in the 
horse include endothelins, nitric oxide synthases (NOS), reactive ox-
ygen species (ROS) and glucocorticoids.
The endothelins comprise three structurally similar peptides, 
that is, endothelin-1, -2 and -3 (ET-1, -2, -3), which act as potent 
vasoconstrictors and pro-angiogenic triggers. They are secreted 
by endothelial as well as other cells, for example smooth muscle 
cells, and their receptors are located on both endothelial and vas-
cular smooth muscle cells (reviewed by Davenport et al., 2016 and 
Bek & McMillen, 2000). Endothelins are the focus of many studies 
in the horse not so much because of their angiogenic but rather 
because of their vasoconstrictive effect. For example, Stokes, 
F I G U R E  4   Tip cell (arrow) followed by stalk cells. Cultured 
equine endothelial cells in a scratch assay. Migration fringe of 
endothelial cells into denuded area to the right. The image is an 
unpublished result from Rieger et al. (2018)
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TA B L E  1   In vitro studies on equine endothelial cells, either describing the isolation procedure or using endothelial cells previously isolated
Topic/aim of study
Organ/vessel of 
origin Authors and title of study
Isolation of endothelial cells and life cell angiogenesis 
assay with primary cultures
Jugular veins and 
carotid arteries
Dietze et al. (2014)
Isolation of equine endothelial cells and life cell angiogenesis 
assay.
Comparison of the angiogenic response of human 
and equine endothelial cells to lesions in an in vitro 
scratch assay
Jugular veins and 
carotid arteries
Rieger et al. (2018)
Human and equine endothelial cells in a live cell imaging scratch 
assay in vitro.
Equine herpesvirus 1 transfer between peripheral 
blood mononuclear cells and endothelial cells
Carotid arteries Spiesschaert et al. (2015)
Role of gB and pUS3 in Equine Herpesvirus 1 Transfer between 
Peripheral Blood Mononuclear Cells and Endothelial Cells: a 
Dynamic In Vitro Model.





Stokes et al. (2006)
Comparison of 2 endothelin-receptor antagonists on in vitro 
responses of equine palmar digital arterial and venous rings to 
endothelin-1.
In vitro thrombosis model for characterisation of 
EHV-1 strain variation. Polarised equine endothelial 
cell cultures on microcarrier beads
Umbilical veins Chiam et al. (2006)
Use of polarised equine endothelial cell cultures and an in vitro 
thrombosis model for potential characterisation of EHV-1 strain 
variation.
Adherence of equine eosinophils to endothelial cells Digital vein Bailey and Cunningham (2001a, 2001b)
2001a: Adherence of eosinophils from allergic and normal ponies 
to cultured equine endothelial cells.
2001b: Inflammatory mediators induce endothelium-dependent 
adherence of equine eosinophils to cultured endothelial cells.
Isolation and characterisation of endothelial cells 
including staining for nitric oxide synthase
Pulmonary artery MacEachern et al. (1997)
Methods for the isolation, culture and characterisation of equine 
pulmonary artery endothelial cells.
Modulation of inflammatory host immune response 
genes in equine endothelial cells through equine 
herpesvirus type 1
Cardiac artery Johnstone, Barsova, Campos, and Frampton (2016)
Equine herpesvirus type 1 modulates inflammatory host immune 
response genes in equine endothelial cell.
Characterization of equine E-selectin on activated 
endothelium for extravasation of leucocytes during 
inflammation
Pulmonary artery Hedges et al. (2001)
Characterization of equine E-selectin.





Venugopal et al. (2001)
In vitro pharmacologic effect of two endothelin-1 antagonists on 
equine colonic arteries and veins.
Cytotoxicity of stimulated equine neutrophils during 
interaction with endothelial cells
Carotid arteries Benbarek et al. (2000)
Cytotoxicity of stimulated equine neutrophils on equine 
endothelial cells in culture.





Wunn et al. (1999)
Culture and characterization of equine terminal arch endothelial 
cells and hoof keratinocytes.
Role of endothelium and nitric oxide Colonic venous 
rings
Moore, Venugopalan, Sedrish, and Holmes (1997)
Role of endothelium and nitric oxide in the in vitro response of 
equine colonic venous rings to vasoconstrictor agents.
Growth characteristics of equine arteritis virus in 
primary equine endothelial cell
Pulmonary artery Moore, Balasuriya, Hedges, and MacLachlan (2002)
Growth characteristics of a highly virulent, a moderately virulent, 
and an avirulent strain of equine arteritis virus in primary equine 
endothelial cells are predictive of their virulence to horses.
Expression of E-selectin and vascular endothelial 
growth factor
Pulmonary artery Huang, Lavoie-Lamoureux, and Lavoie (2009)
Cholinergic stimulation attenuates the IL-4 induced expression 
of E-selectin and vascular endothelial growth factor by equine 
pulmonary artery endothelial cells.
(Continues)
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Venugopal, Hosgood, Eades, and Moore (2006) found ET-1 to be 
a powerful vasoconstrictor of equine palmar digital arteries and 
veins. Comparing endothelin-receptor antagonists, they revealed 
the antagonist PD145065 to be more effective than PD142893 in 
reducing the contractile effects of endothelins. ET-1 antagonists 
have also been tested in equine arterial and venous rings of co-
lonic vessels, where they effectively block ET-1-induced contrac-
tions (Venugopal et al., 2001).
It is known that NOS and ROS are involved in angiogenesis 
(Schroder, 2019), and it has been shown that this is also true for 
equine angiogenesis. NOS are a family of enzymes inducing the 
production of endothelial NO, a free radical regulating vascular 
resistance and blood flow and enhancing angiogenesis (reviewed 
by Tejero, Shiva, & Gladwin, 2019). NOS expression was evalu-
ated in equine endothelial cells of the myometrium (da Costa 
et al., 2007).
ROS production is activated by hypoxia, ischaemia, anoxia–re-
oxygenation, VEGF and Ang1 (Zhou et al., 2013). Equine endothe-
lial cells have been shown to produce ROS in vitro when subjected 
to anoxia–reoxygenation (Anderson & Singh, 2018; de Rebiere de 
Pouyade et al., 2011).
Glucocorticoids are known to act as anti-inflammatory and 
anti-angiogenic agent in rodents and humans (Yano, Fujii, Iwai, 
Kageyama, & Kihara, 2006). Cortisol has been found to down-reg-
ulate inflammation in both, murine and equine species, but, in con-
trast to the mouse, it up-regulates angiogenesis in the horse. The 
reason and detailed pathways of this species-specific regulation of 
angiogenesis have not been studied (Morgan et al., 2018).
Last, not least, there are several cell surface molecules and re-
ceptors relevant to angiogenesis that have been identified in equine 
endothelial cells—although not necessarily in studies on angiogene-
sis but in a different context. Examples are the immunolocalization 
of leptin and ghrelin in equine luteal endothelial cells in vitro (Galvao 
et al., 2014).
5  | ANGIOGENESIS RESE ARCH IN EQUINE 
REPRODUC TION
Angiogenesis research in equine reproduction has been primar-
ily focused on the female genital system and pregnancy. Almost all 
published studies emphasize the clinical relevance of the subject. 
Topic/aim of study
Organ/vessel of 
origin Authors and title of study
Expression of CXCL-8, E-selectin, VEGF, inducible 
nitric oxide synthase mRNA, IL-4 of endothelial cells
Pulmonary artery Huang, Lavoie-Lamoureux, Moran, and Lavoie (2007)
IL-4 stimulates the expression of CXCL-8, E-selectin, VEGF, and 
inducible nitric oxide synthase mRNA by equine pulmonary 
artery endothelial cells.
Isolation and identification of endothelial cells Aorta and 
pulmonary 
arteries
Lamar, Turek, Bottoms, and Fessler (1986)
Equine endothelial cells in vitro.
Mechanism by which equine herpesvirus type 1 is 
transferred from CD172a + cells to endothelial cells
Vena cava Laval et al. (2015)
Equine Herpesvirus Type 1 Enhances Viral Replication in 
CD172a(+) Monocytic Cells upon Adhesion to Endothelial Cells.
Production of free radicals and oxygen consumption 
by endothelial cells
Carotid arteries de Rebiere de Pouyade et al. (2011)
Equine Herpesvirus Type 1 Enhances Viral Replication in 
CD172a(+) Monocytic Cells upon Adhesion to Endothelial Cells.




Turek et al. (1987)
Ultrastructure of equine endothelial cells exposed to endotoxin 
and flunixin meglumine and equine neutrophils.
LPS-induced digital hypoperfusion; vasoactive 
mediators, endotoxin, ibuprofen, cycloheximide, 
or L-nitroarginine methyl ester, prostacyclin, 
cyclic guanosine monophosphate, endothelin-1, 
thromboxane A(2), inducible nitric oxide synthase, 
cyclooxygenase-2
Digital veins Menzies-Gow et al. (2008)
Evaluation of the induction of vasoactive mediators from equine 
digital vein endothelial cells by endotoxin.
Horses and ponies; factor VIII-related antigen, 





Bochsler et al. (1989)
Isolation and characterization of equine microvascular 
endothelial cells in vitro.
Angiogenic stimulating factors in conditioned medium 
of peripheral blood-derived equine mesenchymal 
stromal cells (PB-MSCs) and investigation of their 
in vitro effect on angiogenic-related behaviour of 
endothelial cells
Carotid arteries Bussche and Van de Walle (2014)
Peripheral Blood-Derived Mesenchymal Stromal Cells Promote 
Angiogenesis via Paracrine Stimulation of Vascular Endothelial 
Growth Factor Secretion in the Equine Model.
TA B L E  1   (Continued)
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The principal aims of this research include manipulation of the oes-
trous cycle in mares, therapeutic strategies for anovulatory follicles, 
haemorrhagic corpora lutea and premature luteolysis, therapy of 
endometrial disorders and prevention of abortion. Further studies 
aimed to compare the physiological mechanisms and events be-
tween humans and domestic/ laboratory animals. In addition, the 
regulation of angiogenesis in the equine ovary under physiological 
conditions has been compared to the conditions in tumour growth 
(equine granulosa cell tumour—see section about tumours).
5.1 | Ovary
In the ovary, the development of follicles and corpora lutea 
(CL) as well as their regression is accompanied by rapid changes 
in the vasculature by angiogenesis and anti-angiogenesis 
(Fraser, 2006; Klagsbrun & D'Amore, 1991; Plendl, 2000; Redmer 
& Reynolds, 1996). Follicle growth, ovulation and CL development 
and regression are regulated by signalling pathways that act on the 
vasculature of the ovary (Galvao, Ferreira-Dias, & Skarzynski, 2013; 
Sayasith & Sirois, 2014). Angiogenic activity was monitored by dif-
ferent methods. Measurements of vascular perfusion (Abdelnaby 
& El-Maaty, 2017), capillary density (Ferreira-Dias, Bravo, Mateus, 
Redmer, & Medeiros, 2006; Ferreira-Dias & Mateus, 2003; Watson 
& Ai-zi'abi, 2002), proliferation and apoptosis in situ (Aguilar 
et al., 2006) as well as evaluation of angiogenesis assays in vitro 
(Ferreira-Dias, Costa, et al., 2006) show an increase in angiogenesis 
before ovulation and in the early and mid-luteal phase in the equine 
ovary.
Regulation of angiogenesis in the equine ovary is mediated 
by opposite actions of pro- and anti-angiogenic factors (Galvao 
et al., 2013). Several studies confirmed the role of VEGFs and angio-
poietins and their receptors in the ovary of the mare. Watson and 
Ai-zi'abi (2002) found high VEGF levels together with a high prolifer-
ative activity of endothelial cells in the theca of preovulatory follicles 
(Watson & Ai-zi'abi, 2002). In the mare, anovulatory haemorrhagic 
follicles showed physiological levels of VEGF-A. A relative lack of 
VEGFR-2 affected the pro-angiogenic activity of VEGF leading to 
ovulation failure (Ellenberger et al., 2009). Muller, Ellenberger, and 
Schoon (2009) did a histomorphological and immunohistochemical 
study of angiogenesis on cyclic ovaries of mares. The most intensive 
co-expression of the factors VEGF-A, VEGF-B, Ang1 and Ang2 and 
the receptors VEGFR-1, VEGFR-2 and Tie2 was detected during the 
periovulatory period, when strong ovarian angiogenesis takes place. 
The authors propose VEGF-A, Ang2, VEGFR-2 and Tie2 to be im-
portant for angiogenesis during follicular and luteal development, 
while Ang1 stabilizes vessels. In the absence of VEGF-A, Ang2 and 
Tie2 contributed significantly to vascular regression and thus to lu-
teolysis and follicular atresia (Muller et al., 2009).
A high expression of VEGF in follicles stimulated by intrafol-
licular injection of insulin-like growth factor (IGF)-1 was detected 
during follicle selection by Ginther, Gastal, Gastal, Checura, and Beg 
(2004). The role of cytokines in the control of luteal angiogenesis 
was investigated in an in vitro study with equine ovaries by Galvao 
et al. (2012). The results suggest an auto/ paracrine effect, espe-
cially of tumour necrosis factor (TNF), on the up-regulation of VEGF 
to stimulate angiogenesis in early CL, while the cytokines examined 
down-regulated angiogenesis during luteolysis. TNF increased the 
angiogenic activity of VEGF and decreased the expression of CD36, 
the receptor for thrombospondin (Galvao et al., 2012). Comparing 
natural and deslorelin (GnRH analogue)-induced ovulation, Maia 
et al. (2016) found a positive correlation between the expression of 
VEGF and the LH-receptor in mares with natural ovulation and an 
increased expression of the LH-receptor in induced ovulation.
The action of hormones, cytokines and angiogenic factors 
changes depending on the luteal phase. Maturation and ovulation 
of the dominant follicle in mares were accompanied by increasing 
levels of estradiol and leptin and a decreasing level of IGF-1. On 
day 3 before ovulation, NO peaked and thereafter decreased until 
ovulation (Abdelnaby & El-Maaty, 2017). The effect of TNF and NO 
on the production of angiogenic factors and prostaglandin E2 was 
studied in cultured equine explants of corpora lutea (Ferreira-Dias 
& Skarzynski, 2008). The secretory function and the release of an-
giogenic factors of equine corpora haemorrhagica were found to be 
stimulated by TNF and NO (Ferreira-Dias et al., 2011). During the 
late luteal phase, NO and progesterone 4 inhibit angiogenesis, pre-
paring the CL for functional and structural regression (Ferreira-Dias 
& Skarzynski, 2008). Leptin and ghrelin play opposing roles during 
development and regression of the equine CL, with leptin promoting 
angiogenesis and ghrelin enhancing luteolysis (Galvao et al., 2014).
5.2 | Uterus, placenta and conceptus
Vascular density in histological sections of the equine endometrium 
was found to be similar in the follicular and luteal phase (da Costa 
et al., 2007; Ferreira-Dias & Mateus, 2003; Ferreira-Dias, Serrao, 
Durao, & Silva, 2001; Otzen et al., 2016), indicating that vascular and 
stromal growth are coordinated. Similar results were presented by 
Merkl et al. (2010) in early equine pregnancy. Using narrow band im-
aging hysteroscopy, Otzen et al. (2016) found an increase in vascular 
density from oestrus towards diestrus, while results from histomor-
phology and immunohistochemistry suggested that the higher vas-
cularity measured in vivo is not due to angiogenesis, but caused by a 
higher perfusion of the existing capillaries (Otzen et al., 2016).
Throughout the oestrous cycle, VEGF and its receptor VEGFR-1 
were localized in lumenal and glandular epithelia of the endome-
trium, in the invasive trophoblast cells of the endometrial cups and 
in the non-invasive trophoblast of the allantochorion. VEGFR-2 was 
found in maternal epithelium during the oestrous cycle as well as in 
the foetal epithelium in pregnancy. Likewise, anti-VEGFR-2 stained 
the maternal and foetal endothelia of the placenta (Allen, Gower, & 
Wilsher, 2007). Silva, Klein, Ealy, and Sharp (2011) examined endome-
trial tissue during different cyclic stages and throughout pregnancy. 
They found no differences in VEGF and VEGFR-1 protein localization 
between pregnant and cycling mares, whereas a differential staining 
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pattern was detected for VEGFR-2 with higher levels in luminal and 
glandular epithelium of pregnant mares. Additionally, VEGFR1 stain-
ing in the equine endometrial tissue was described to be essentially 
absent during the oestrus, while the opposite was true during di-
estrus (Silva et al., 2011).
Angiogenic activity in the equine endometrium during the follicu-
lar and luteal phases was found to be related to an increase of NO and 
was stimulated by treatment with TNF, oestradiol and oxytocin. TNF 
and NO increased prostaglandin secretion of the endometrium in the 
early and mid-luteal phases (da Costa et al., 2008; Galvao et al., 2013).
A systematic analysis by Merkl et al. (2010) of transcriptome 
changes in equine endometrial biopsy samples at day 8 and 12 of 
pregnancy revealed 374 differentially expressed genes at day 12. 
The expression of genes seemed to be regulated by oestrogen, pro-
gesterone and prostaglandins. Changes in the expression of genes 
related to angiogenesis and vascular remodelling were identified. 
These genes are involved in the dynamics of the VEGF and angiopoi-
etin families, endothelial cell regulators and hypoxia-induced genes 
as well as genes acting on inhibition of endothelial cells and angio-
genesis (Merkl et al., 2010).
Milk-fat globule epidermal growth factor 8 (MFGE8) seems to 
be involved in regulating angiogenesis at the embryo– and foetal–
maternal interface during early pregnancy, persisting at the foetal–
maternal interface, where it is located, inter alia, in the pericytes 
of endometrial blood vessels. Expression of MFGE8 was found to 
be up-regulated by oestrogen in non-pregnant endometria (Barua, 
Macedo, Kolb, Wynne-Edwards, & Klein, 2018).
Brain-derived neurotrophic factor (BDNF) and its receptor 
(Ntrk2) were found in the endometrium, myometrium and vascular 
smooth muscle cells in many species including the horse. The factor 
is capable of activating angiogenesis as well as cell adhesion, apop-
tosis and proliferation pathways (Wessels, Wu, Leyland, Wang, & 
Foster, 2014).
The role of relaxin in mare reproduction was reviewed by Klein 
(2016). During pregnancy, relaxin promotes endometrial angiogene-
sis through up-regulation of VEGF. Relaxin messenger RNA was also 
found as early as 8 days after ovulation in the conceptus, possibly 
driving endometrial angiogenesis and promoting the embryo´s own 
development (Klein, 2016). Thus, conceptus-derived relaxin could be 
involved in the control of angiogenesis in the endometrium and in 
the embryo itself.
Equine microRNA cluster C24MC, related to the human chromo-
some 14 microRNA cluster C14MC, was demonstrated during early 
stages of pregnancy in the vascular endothelium, chorion and allan-
toic epithelium. Functional analysis indicated a relation to endothe-
lial cell migration and angiogenesis (Dini et al., 2018).
Recently, the proteomic profile of uterine secretions (histotrophs) 
in pregnant and cyclic mares was reported by Bastos et al. (2019). 
They found an abundance of proteins related to angiogenesis, uter-
ine motility and maternal immunological tolerance. These alterations 
were related to the presence of the conceptus and may be important 
for maternal recognition of pregnancy and the development of the 
embryo (Bastos et al., 2019).
5.3 | Testis
Treatment of prepuberal stallions with the anabolic steroid testos-
terone had a temporary effect on vascular density and the expres-
sion of angiogenic factors and their receptors. The highest volume 
density and numerical density of capillaries and the smallest vessel 
sizes were measured morphometrically at 4 weeks after treatment 
with the testosterone derivative Durateston. This effect was related 
to the highest expression of transforming growth factor (TGF), Ang2 
and VEGFR-2 and considerably reduced after 12 weeks, suggesting 
an only temporary stimulation of the blood vessels by the anabolic 
steroid Durateston (Teubner et al., 2015).
Expression of constitutive endothelial NOS was found in the 
equine testis and epididymis (Ha, Kim, & Shin, 2004).
5.4 | ANGIOGENESIS RESEARCH IN 
PATHOLOGICAL CONDITIONS
Angiogenesis in the healthy organism is tightly regulated and—with 
a few exceptions—down-regulated in the adult. However, up-regu-
lation of angiogenesis is involved in many diseases, the best known 
examples are solid tumours. Their growth and metastasis are de-
pendent on angiogenesis (Folkman, 1971). The fragmentary knowl-
edge on the role of angiogenesis in equine pathological conditions is 
presented in the following chapter.
5.5 | Tumours
Increased angiogenesis plays a crucial role in the equine sarcoid, a 
frequent neoplasm of horse skin without effective treatment option 
(Knottenbelt, 2019). In this tumour, VEGF is highly expressed due to 
hypoxia, leading to inadequate, immature vascularization. VEGF was 
found in endothelial cells as well as in keratinocytes and fibroblasts of 
sarcoid tumour samples by Martano et al. (2018). The authors conclude 
that VEGF may stimulate tumour growth by activation of angiogenesis.
Müller et al. investigated angiogenesis in the equine ovary (Muller 
et al., 2009) and ovarian tumours (Muller, Ellenberger, Hopper, & 
Schoon, 2012). They reported that the equine granulosa cell tumour, 
which is the most common benign ovarian neoplasia in the mare, was 
characterized by the patterns of expression of VEGF-A, VEGF-B, 
Ang1, Ang2, VEGFR-1, VEGFR-2 and Tie2 similar to expression pat-
terns in the normal ovaries. In this tumour, the angiogenic factors are 
expected to contribute significantly to angiogenesis and vasculariza-
tion (Muller et al., 2012).
Grey horses have a genetic predisposition to spontaneously 
develop melanomas. Many of these tumours are well-vascularized, 
reflecting enhanced angiogenesis (Moore et al., 2013). Preclinical 
studies with grey horses have demonstrated that immunotherapy 
with a plasmid encoding the cytokine IL-12, known to be a potent 
anti-angiogenic agent, leads to a pronounced reduction in tumour 
growth (Heinzerling et al., 2001).
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Finally, Bartonella species are known to be potential causes of 
proliferative vascular diseases in humans and different animals. It 
has been reported that some Bartonella species can induce prolifer-
ation of endothelial cells and are associated with in vivo formation of 
vasoproliferative tumours in horses (Beerlage et al., 2012; Cerimele 
et al., 2003). The exact mechanism of action of the bacteria is not 
known; however, it has been shown that they are able to induce an-
giogenesis in pro-angiogenic circulating progenitor cells (O'Rourke 
et al., 2015).
5.6 | Ocular pathologies
Physiologically, the cornea is an avascular tissue that maintains its 
transparency by regulating its optimal consistency based on an equi-
librium of pro- and anti-angiogenic factors including endostatin, an-
giostatin and MMPs. Any disequilibrium of factors, which may be the 
case in hypoxia or inflammatory diseases, initiates angiogenesis in 
the cornea (Shank, Teixeria, & Dubielzig, 2019).
Equine recurrent uveitis (synonym moon blindness) is a frequent 
cause of blindness in horses that is accompanied with angiogenesis 
in the cornea (Figure 5). Amongst others, leptospirosis has been im-
plicated as an infectious cause (review see Allbaugh, 2017). The dis-
ease serves as a model for human uveitis, where, in a similar fashion, 
T lymphocytes target retinal proteins (Zipplies et al., 2010). Hauck 
and colleagues examined proteins of lymphocytes at different stages 
of equine recurrent uveitis and identified considerable differences 
in angiogenesis-related proteins including integrins (Hauck, Lepper, 
Hertl, Sekundo, & Deeg, 2017). Moreover, quantitative changes in 
MMPs, important angiogenic factors, have been found in equine re-
current uveitis (Hofmaier, Hauck, Amann, Degroote, & Deeg, 2011). 
Another study revealed that high-molecular-weight kininogen, a 
plasma protein enhancing angiogenesis, was significantly up-regu-
lated in the retina of horses with equine recurrent uveitis (Zipplies 
et al., 2010).
Angiogenesis of the cornea can also be a consequence of 
post-traumatic keratouveitis. Moore and colleagues studied this 
condition in horses and revealed the presence of leucocytes as well 
as growth factors and cytokines such as; IL-1, IL-2 fibroblast growth 
factor 2 (FGF-2) and VEGF with a stimulating effect on corneal an-
giogenesis (Moore, Halenda, Grevan, & Collins, 1998).
In human patients suffering from corneal neovascularization, 
promising results have been described for antibodies binding VEGF. 
Muellerleile, Buxbaum, Nell, and Fux (2019) examined binding of the 
anti-human VEGF antibodies bevacizumab (Avastin®) and afliber-
cept (Zaltrap®) for equine VEGF. Unfortunately, the veterinary pa-
tients did not benefit from this therapeutic approach because the 
antibody that binds VEGF is species-specific.
Pearce, Janardhan, Caldwell, and Singh (2007) examined the 
presence of the anti-angiogenic molecule angiostatin and the 
pro-angiogenic integrin αVβ3 in the retina and cornea of different 
mammalian species including the horse. Whereas angiostatin was 
present, integrin αVβ3 was absent in the normal equine cornea and 
retina (Pearce et al., 2007).
5.7 | Equine wound healing
Wound repair is a process dependent on intense but strictly con-
trolled angiogenesis (DiPietro, 2016). In horses, it is known to be 
subject to numerous complications (Theoret, 2004). In physiologi-
cal wound healing, endothelial cells migrate into the wound space 
together with fibroblasts and macrophages. Macrophages are a con-
tinuous source of cytokines and growth factors necessary to stimu-
late angiogenesis. Fibroblasts form new extracellular matrix and new 
blood vessels carry oxygen and nutrients needed for cell metabolism. 
Interestingly, wounds heal faster in ponies than in horses. This seems 
to be due to differences in the local inflammatory response and leu-
cocyte function (Wilmink & van Weeren, 2005). In terms of wound 
healing models, rodent models have been criticized because wound 
healing occurs primarily by contraction rather than by epithelializa-
tion, contrary to what is observed in humans. The horse's wound 
healing behaviour is more like that of humans (Wise et al., 2018).
Wound healing in horses is studied in several ways. A fundamen-
tal approach is the use of in vitro wound healing assays such as the 
scratch assay, done by scratching an endothelial monolayer followed 
F I G U R E  5   Corneal angiogenesis is evident in keratouveitis due to an intraocular response to leptospiral infection in two Haflinger horses. 
In image (a), elongate arborizing vessels are clearly evident. In image (b), numerous short vessels (arrow) occur circumferentially starting at 
the corneoscleral junction. Pictures provided by Univ.-Prof. Dr. Corinna Eule, Dipl. ECVO, Small Animal Clinic, Department of Veterinary 
Medicine, Freie Universität Berlin
(a) (b)
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by studying endothelial migration and cell–cell interaction during 
closure of the “wound gap”. Human and equine endothelial cells re-
vealed differences in this wound healing assay. In a scratch assay, 
horses' arterial endothelial cells, compared to equine or human ve-
nous endothelium, showed a delay in closing the gap and re-endo-
thelialization, possibly as a result of disoriented and uncoordinated 
migration of endothelial tip cells (Rieger et al., 2018). In an aortic ring 
model, where aortic explants were cultured in a three-dimensional 
biomatrix, and in scratch assays, Pascucci et al. (2014) examined the 
response of endothelial cells to membrane vesicles. The vesicles, 
which were produced by equine adipose-derived mesenchymal stro-
mal cells, were found to be involved in intercellular communication 
with endothelial cells from rats and to stimulate angiogenesis, which 
is a crucial step in tissue regeneration (Pascucci et al., 2014).
Basic wound healing principles are also studied in vivo in the 
horse. In horses, injuries, especially on the limbs, often develop a 
persistent inflammation. They have an inefficient blood supply, 
leading to excessive fibrosis and clinical complications such as ex-
uberant granulation tissue (Wakelin et al., 2016). This complication 
of wound healing in horses is characterized by highly vascularized 
tissue that clinically behaves like a benign tumour. The developing 
scar remains chronically in the proliferative repair phase, resulting in 
fibrosis. Extensive scars are the result that can affect form and func-
tion (Miragliotta, Raphael, Ipina, Lussier, & Theoret, 2009). Wakelin 
(2015) applied VEGF-E to improve wound closure and resolution in 
chronic wounds in horses. Although inflammatory mediators and in-
nate immune cell infiltration decreased and angiogenesis increased, 
she concluded that the dosage and timing for VEGF-E treatments 
had to be optimized to achieve therapeutic benefits (Wakelin, 2015).
The distribution and reaction of microvessels are heterogenous in 
different anatomical regions of the body. Over most of the body sur-
face the skin is supplied by small capillaries, that is functional nutrient 
vessels; while in the bodies’ extremities, arterioles and venules pre-
dominate with their inherent lower resistances and higher flow rates. 
Accordingly, the response of these areas to lesions—vasodilation in 
the skin and vasoconstriction in the distal limbs—varies (Celeste, 
Deschesne, Riley, & Theoret, 2013). Celeste et al. (2013) investigated 
blood flow during cutaneous wound healing with a focus on exuber-
ant granulation tissue formation in the horse: interestingly, although 
more angiogenesis occurs in exuberant granulation tissue, functional 
perfusion was found to be poorer because the microvessels were 
occluded (Celeste et al., 2013). Occlusion of granulation tissue mi-
crovessels is seen frequently and seems to be caused by endothelial 
cell hypertrophy (Dubuc, Lepault, & Theoret, 2006). It was concluded 
that it is not the number of blood vessels that is crucial but their func-
tionality (Celeste et al., 2013). Microvascular occlusion followed by 
hypoxia is likely to result in excessive production of extracellular ma-
trix components by fibroblasts through up-regulation of angiogenic 
and fibrogenic factors such as TGF-β (Wilmink & van Weeren, 2005).
Ipina, Lussier, and Theoret (2009) investigated wound heal-
ing in experimentally induced wounds on the trunk and limbs of 
horses. They investigated the temporal expression of equine pig-
ment epithelium-derived factor (PEDF) that is known to have potent 
anti-angiogenic properties. Equine PEDF shares 87% sequence and 
88% peptide homology with human PEDF. A relative overexpression 
of PEDF in the trunk's wounds compared to those of the limbs was 
reported. The authors concluded that a higher expression of PEDF in 
trunk wounds may contribute to better healing by protecting against 
overgrowth of vascular granulation tissue (Ipina et al., 2009).
According to Miragliotta et al. (2009), equine thrombospondin II 
(THBS2) and secreted protein acidic and cysteine-rich (SPARC) are 
up-regulated during wound healing in horses and may modulate an-
giogenesis. The glycoproteins THBS2 and SPARC are matricellular 
proteins that modulate cell–matrix interactions and participate in 
tissue repair by simultaneously binding to other matrix proteins, cell 
surface receptors and molecules such as proteinases and cytokines. 
Both exhibit potent anti-angiogenic activities. SPARC inhibits the 
proliferation and migration of endothelial cells stimulated by FGF-2 
and VEGF and is reported to disrupt the VEGF/ VEGFR-1 signal-
ling pathway. It was found to be significantly less expressed in the 
equine limb. The absence of THBS2 is associated with persistence of 
blood vessels through the later stages of wound repair (Miragliotta 
et al., 2009).
Due to the often unsatisfactory wound healing in horses, re-
search focusses on different treatment strategies.
The working group of Christine Theoret (https://www.resea 
rchga te.net/profi le/Chris tine_Theor et/research) performed sev-
eral wound healing experiments in the horse focussing on the 
treatment of dermal fibroproliferative disorders. They found that 
the treatment of wounds in horses using the Orf virus IL-10 (a ho-
molog of interleukin-10 encoded by the parapoxvirus orf virus) 
and VEGF-E had an anti-inflammatory and repair-promoting ef-
fect without accelerating wound closure. Enhanced angiogenic 
gene expression was found mainly in body wounds in which the 
blood vessel density and persistence of myofibroblasts were al-
tered. Prolonged healing of horse leg wounds appears to be as-
sociated with increased and prolonged proinflammatory gene 
expression, which is associated with an enhanced immune re-
sponse. The inflammatory cells that remain in the wounds of the 
limbs excrete molecules (e.g. TNFα) that potentiate angiogenic 
stimuli. Furthermore, there seems to be a lack of the anti-inflam-
matory effect of equine IL-10. In addition, initially blood vessels 
are more permeable and may mature later due to the delayed 
production of angiogenic factors following injury. This may be 
due to a delayed production of platelet-derived growth factor-b 
(PDGF), necessary to coordinate the pericyte coverage of vascular 
sprouts for vascular stabilization during angiogenesis. Although in 
the horse VEGF-A has been shown to promote epithelialization 
by up-regulating keratinocyte proliferation, VEGF interaction with 
the VEGFR-1 may result in the formation of immature blood ves-
sels, prolonged vascular leakage and inflammation of the tissue 
(Bodaan et al., 2016; Wise et al., 2018). Although corticosteroids 
may be used initially in the treatment of exuberant granulation 
tissue, continued use is not recommended because it may inter-
fere with angiogenesis, wound contraction and epithelialization 
(Wilmink & van Weeren, 2005).
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The application of dressings to wounds promotes the forma-
tion of exuberant granulation tissue. Dressings increase the oxygen 
gradient between the damaged tissue and the surface, which can 
stimulate angiogenesis, reduce tissue oxygen tension and stimulate 
fibroblastic proliferation (Wilmink & van Weeren, 2005).
Silver nanoparticles enhanced equid distal limb wound healing in 
donkeys. Following topical treatment, extensive neovascularization 
and the presence of few fibroblasts and collagen fibres perpendicu-
lar to the newly formed blood vessels and parallel to the wound sur-
face were observed (Khafaga, Abu-Ahmed, El-Khamary, Elmehasseb, 
& Shaheen, 2018).
Protein C (autoprothrombin IIA/coagulation factor XIV) is a zy-
mogen whose activated form plays an important role in the regulation 
of anticoagulation, inflammation, cell death and the maintenance of 
the permeability of blood vessel walls. Activated protein C suppos-
edly improves angiogenesis and may have potential to reduce inflam-
mation and promote physiological angiogenesis, furthering healing 
of equine distal limb wounds (Bischofberger et al., 2015). According 
to Carmona, Lopez, and Giraldo (2011), platelets are crucial in wound 
healing. They contain numerous growth factors in their α-granules 
and can release them specifically. They cause chemotaxis, cell pro-
liferation as well as differentiation, angiogenesis and extracellular 
matrix deposition. The use of autologous platelet concentrates to 
accelerate wound healing, reduce inflammation, stimulate the re-
generation capability of injured tissues, reduce fibroblastic activity 
and prevent the production of non-functioning scar tissue has been 
suggested for the horse. Some growth factors and chemokines con-
tained in platelet α-granules stimulate equine angiogenesis (PDGF, 
TGF-β, VEGF, FGF-2, hepatocyte growth factor) while others have 
anti-angiogenic properties (Platelet factor 4) (Carmona et al., 2011).
Insect products, particularly those of the European honey bee 
(Apis mellifera), have been reported to promote wound healing by 
stimulating angiogenesis, granulation tissue formation, epitheliali-
zation, reduction of wound hyperaemia and their broadband anti-
bacterial properties (Bischofberger et al., 2016; Hananehl, Ismail, 
Alshehabat, & Ali, 2015).
A clinical study using essential oils from the aromatic medici-
nal plant pepper-rosmarin (Lippia sidoides) as a mouthwash in oral 
wounds of horses elicited an intensive stimulation of angiogenesis. 
This could be because of its high levels of thymol and carvacrol but 
also may be due to some, as yet unknown, substance (de Alencar-
Araripe et al., 2014).
Low oxygen content in tissues is one of the problems in wound 
healing. Therefore, in human medicine, topical oxygen therapy is 
used to promote healing of chronic wounds. In contrast, in horses, 
this experimental approach had little effect on the healing of 
wounds, although angiogenesis showed a trend towards increased 
blood vessel density (Tracey et al., 2014).
Finally, non-steroidal anti-inflammatory drugs (NSAIDs) are used 
regularly to suppress inflammation and pain. Administration of phen-
ylbutazone has been shown to reduce the expression of pleiotropin, 
a cytokine and growth factor known to be involved in angiogene-
sis and bone growth. Pleiotropin is an important mediator of cell 
migration and thus a potential target by which NSAIDs can inhibit 
wound healing (Silver, Desormaux, Freeman, & Lillich, 2012).
5.8 | Musculoskeletal system
The musculoskeletal system is of eminent importance for the horse 
as an athlete. Eivers et al. (2012) investigated gene expression 
in response to exercise of the skeletal muscles in Thoroughbred 
horses. Peroxisome proliferator-activated receptor-γ coactivator 1α 
(PGC-1α) was found to be an important control factor in adaptation 
of the skeletal muscle to exercise, acting via transcriptional control 
of genes amongst others responsible for angiogenesis. Expression of 
PPARGC1A, the gene encoding PGC-1α, was found to be significantly 
correlated with genes involved in angiogenesis (ANGP2 and VEGF-A) 
(Eivers et al., 2012).
Mechanical properties and functional anatomy of tendons and 
ligaments of the equine distal limb are of critical significance in this 
species (Denoix, 1994). These bradytrophic anatomic structures are 
crucially dependent on blood supply and appropriate vasculariza-
tion. Degenerative lesions in draught horses are particularly obvious 
at the endothelial level of the distal deep digital flexor tendon. Here, 
endothelial proliferation and angiogenesis, endothelial cell oedema, 
metaplasia and finally apoptosis and necrosis lead to endothelial 
desquamation and clinical problems (Crisan et al., 2013).
Platelet-rich plasma (PRP) is an autologous platelet concentrate 
and a potential treatment commonly used in orthopaedic medicine 
for tendon and ligament injuries. It is rich in growth factors, has been 
proven to improve the repair process of injured tendons and can be 
injected directly into the tendon. Vascularization is important during 
the healing process and an increase during the proliferative phase of 
healing appears to be beneficial. The potent stimulator of angiogen-
esis VEGF is abundant in PRP, suggesting that the enhancement of 
neovascularization may be one of its working mechanisms. It should 
be noted that this treatment is recommended for acute lesions and 
not for chronic ones. After the healing of a tendon lesion is com-
pleted, the vascular system usually recedes and it has been sug-
gested that the prolonged presence of blood vessels may play a role 
in prolonged pain and healing of tendon injuries (Bosch et al., 2011). 
Autologous platelet concentrate is also used in intra-articular ther-
apy for horses with refractory fetlock osteoarthritis. This approach 
takes advantage of the growth factors it contains that are known 
to have anabolic and angiogenic properties and have a positive ef-
fect on synovial epithelium, cartilage and pain (Pichereau, Decory, & 
Ramos, 2014).
Gene therapy using plasmid DNA encoding VEGF164 and FGF2 
genes was proposed as a novel treatment of naturally occurring ten-
dinitis and desmitis in horses. The authors report positive effects 
after treatment and rely this effect to stimulation of angiogene-
sis (Kovac et al., 2018). Litvin, Zakirova, Zhuravleva, and Rizvanov 
(2016) generated a dual expression cassette plasmid DNA (pDNA) 
construct containing the species-specific horse (Equus caballus) se-
quence encoding the pro-angiogenic factors VEGF-A and FGF-2 
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under eukaryotic promoters (EF-1 alpha and CMV promoters, re-
spectively). They showed recombinant protein expression in vitro 
and stated that the resulting pDNA is suitable for potential gene 
therapy applications in horses (Litvin et al., 2016). In a follow-up clin-
ical study, this direct gene therapy was used to restore severe inju-
ries of the suspensory ligament branch and superficial digital flexor 
tendon in horses (Kovac et al., 2017). The pDNA (VEGF164 and FGF-
2) was injected at the site of injury with the expectation of a positive 
influence on the regeneration of the vessels and connective tissue. 
It was postulated that VEGF164 increased vascular permeability at 
the site of injury, promoting the formation of granulation tissues, 
attracting endothelial progenitor cells, stimulating angiogenesis and 
increasing the activity of pericytes that stabilize newly formed ves-
sels. FGF-2 stimulated cell proliferation, regeneration of nerve, mus-
cle and connective tissue. The treatment led to a complete recovery 
within a period of 2–3 months (Kovac et al., 2017).
Placental stem cells are reported to be one of the most promis-
ing stem cell sources for the regeneration of tendons. They control 
the healing of the tendons by stimulating an immediate restoration 
of tissue function without prior transfection. It is believed that the 
release of pro-angiogenic factors enhances the endogenous regen-
erative environment (Barboni et al., 2018).
Side effects of NSAIDs (e.g. phenylbutazone) have already been 
mentioned in the context of equine wound healing. These substances 
also inhibit equine bone healing. The inhibition of angiogenesis has 
been suggested as a mechanism of NSAID negative effects on bone 
healing, since the metabolic products (mainly prostaglandins) of cy-
clooxygenase-2, a biological target of NSAIDs, are stimulators of an-
giogenesis and thus essential for fracture healing (Barry, 2010).
5.9 | Laminitis
Laminitis is a disease that occurs in horses and other ungulates. 
Inflammation of the laminae of the hoof can cause the hoof capsule 
to detach from the dermis. Acute laminitis is a common condition 
in horses that often becomes chronic and can even lead to death 
(Katz & Bailey, 2012). Acute laminitis often develops following a vari-
ety of primary diseases; therefore, there are numerous mechanisms 
involved in its pathogenesis (Eades, 2010). Huntington, Pollitt, and 
McGowan (2008) consider five hypotheses for how laminitis initially 
damages the hoof's lamellae. These are the enzymatic, inflammatory, 
vascular, metabolic/endocrine and mechanical/traumatic theories. 
Katz and Bailey (2012) subdivide the various forms of naturally ac-
quired laminitis into two categories, that is endocrinopathic and sep-
sis-related (nonendocrine) forms of laminitis, where endocrinopathic 
laminitis arises from hormonal rather than inflammatory conditions 
and is associated with obesity and insulin resistance.
The vascular endothelium plays a major role in the early stages 
of equine laminitis, consequently, the equine digital vascular endo-
thelium and blood vessels became a subject of numerous studies for 
a better understanding of the pathogenesis mechanisms and for the 
development of novel therapeutic approaches.
In both, insulin resistance and sepsis-related conditions, the dig-
ital vascular endothelium dysfunction is likely to play a major role in 
the pathogenesis mechanisms in acute laminitis. Sepsis-related lam-
initis seems to be the result of two local events. The first is a sys-
temic inflammatory syndrome inducing severe endothelial alteration 
(Angelone et al., 2017) and the second is the change in digital blood 
vessel tone and haemodynamics resulting in decreased lamellar blood 
flow as result of the increase of the post-capillary resistance. (Allen, 
Clark, Moore, & Prasse, 1990). The inflammatory events, which lead 
to laminar failure in septic horses, seem to be similar to the organ fail-
ure occurring in human sepsis. These events include leucocyte acti-
vation, endothelial activation and leucocyte adhesion, extravasation 
and emigration as well as activation of degradative enzymes (MMPs) 
and the presence of oxidative stress (Belknap et al., 2007; Belknap, 
Moore, & Crouser, 2009; Loftus, Black, Pettigrew, Abrahamsen, & 
Belknap, 2007). The migration of leucocytes through the activated 
vascular wall to the epithelial–dermal interface plays a significant role 
in initiating laminar proinflammatory cytokine expression leading to 
the development of laminitis (Black et al., 2006; Faleiros et al., 2009). 
The dysadhesion of laminar basal epidermal epithelial cells from their 
basement membrane seems to be the main cause of structural failure 
in equine laminitis (Black et al., 2006; Faleiros et al., 2009).
The role of endothelial cells in equine laminitis has been analysed 
and discussed for decades. As early as 1987, Turek, Lamar, Fessler, 
and Bottoms exposed primary equine cell lines from pulmonary ves-
sels and aortae to varying combinations of endotoxin and the cy-
clooxygenase inhibitor flunixin meglumine and equine neutrophils. 
Then they evaluated the endothelial cells by transmission electron 
microscopy. Endotoxin alone did not cause cell damage, but endo-
toxin plus neutrophils caused pathological changes in the endothe-
lial cells. The cells became round and had cytoplasmic vacuolization, 
mitochondria were swollen and distorted (Turek, Lamar, Fessler, & 
Bottoms, 1987).
In the early stage of acute laminitis, vascular endothelial dys-
function led to the up-regulation of adhesion molecules that pro-
mote adherence of platelets and leucocytes (Katz & Bailey, 2012). 
Loftus et al. (2007) found that endothelial activation and laminar 
inflammation are early events in equine laminitis. Laminar concen-
trations of endothelial activating cytokines such as IL-1β, IL-6, IL-8, 
COX-2, endothelial adhesion molecules like intercellular adhesion 
molecule 1 (ICAM-1), and E-selectin were significantly increased 
in horses with laminitis, compared with that of control horses. 
Furthermore, concentrations of IL-1β, IL-8, ICAM-1 and E-selectin 
mRNA peaked early at 1.5 hr after the application of Black wal-
nut extract, which induced laminitis in horse (Loftus et al., 2007). 
Loftus et al. (2007) reported that the activation of endothelial pat-
tern recognition receptors (toll-like receptors) by circulating tox-
ins induced IL-8 gene expression. Subsequently, Xing et al. (2012) 
found that IL-8 enables the binding of leucocytes to the endothe-
lium, which is essential for ensuing leucocyte emigration (Xing 
et al., 2012).
E-selectin and ICAM-1 are endothelial adhesion molecules, 
which are important in IL-8-mediated neutrophil adhesion and 
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extravasation (Collins et al., 2000; Loftus et al., 2007). Loftus 
et al. (2007) found that E-selectin and ICAM-1 mRNA concentrations 
peaked early in the condition and then they decreased noticeably 
thereafter. Thus, they concluded that endothelial inflammation and 
activation could be the initiating event leading to laminar failure.
Brooks et al. (2009) investigated the role of p38 mitogen-acti-
vated protein kinases (MAPKs) in endotoxin-induced activation of 
equine digital vein endothelial cells. P38 MAPK, which is triggered 
by VEGFR2, is important for shear stress-induced angiogenesis (Gee, 
Milkiewicz, & Haas, 2010). Brooks et al. (2009) exposed cultured 
equine digital vein endothelial cells to endotoxin (lipopolysaccharide 
[LPS]) and assessed the phosphorylation of p38 MAPK by Western 
blotting. Furthermore, they quantified the neutrophil adhesion and 
studied the effects of p38 MAPK inhibitors on neutrophil adhesion. 
They found that the binding of endotoxin to endothelium initiated 
activation of the p38 MAPK, which was involved in the initiation of 
inflammatory responses. Furthermore, the presence of p38 MAPK 
inhibitors significantly inhibited neutrophil adhesion to endotox-
in-stimulated endothelial cells. The authors suggested that inhibition 
of p38 MAPK might reduce inflammatory events in the endotoxemic 
horse (Brooks et al., 2009).
Moreover, Brooks, Menzies-Gow, Bailey, Cunningham, and 
Elliott (2010) described the effect of endotoxin (LPS) and hypoxia 
on cultured equine digital vein endothelial cells. They revealed that 
the two stimuli significantly increased hypoxia-inducible factor 1α 
(HIF-1α), neutrophil adhesion and endothelial permeability, all en-
hancing tissue damage. The endothelial permeability in response to 
both stimuli was dependent on p38 MAPK and HIF-1α. It was con-
cluded that inhibitors of HIF-1α could reduce unwanted effects in 
the endotoxemic horse (Brooks et al., 2010).
In laminitis, digital vasoconstriction associated with oxidative in-
jury caused by ischaemia–reperfusion injury occurs. Endotoxin can 
modify the local qualitative–quantitative balance of vasoactive sub-
stances or vessel responsiveness resulting in haemodynamic alter-
nation (Zizzadoro et al., 2011).
The most notable vasoconstrictors acting on the equine digi-
tal blood vessels are norepinephrine, 5-hydroxytryptamine (sero-
tonin) and endothelin-1 (ET-1) (Baxter, Laskey, Tackett, Moore, & 
Allen, 1989; Eades et al., 2007; Menzies-Gow, Bailey, Katz, Marr, & 
Elliott, 2004). ET-1 is the most potent endothelium-derived vasocon-
strictor, it interacts with endothelial-derived relaxing factors such 
as NO and prostacyclin to control the local vascular flow (Masaki & 
Sawamura, 2006). Eades et al. (2007) assessed ET-1 immunoreactiv-
ity in digital and jugular venous blood from horses with carbohydrate 
overload-induced laminitis. After 11 hr of carbohydrate overload, 
they found a significant increase from baseline in digital blood ET-
like immunoreactivity. Moreover, the ET-like immunoreactivity of 
digital blood was significantly greater than that of the jugular vein 
(Eades et al., 2007).
Menzies-Gow, Bailey, Berhane, Brooks, and Elliott (2008) incu-
bated equine digital vein endothelial cells with or without endotoxin 
(LPS) and determined concentrations of vasoactive mediators at dif-
ferent time intervals. The production of the vasoactive mediators 
prostacyclin, cyclic guanosine monophosphate, ET-1 and thrombox-
ane A2 was found to be stimulated by endotoxin.
Furthermore, in relation to vasoactive properties, the equine 
digital arteries and veins are unique (Bailey & Elliott, 1998; Katz, 
Marr, & Elliott, 2003; Peroni et al., 2006). It has been confirmed that 
several vasoconstrictors (including serotonin and ET-1) are more 
potent vasoconstrictor of equine digital veins than arteries (Peroni 
et al., 2006).
Katz and Bailey (2012) described how the endothelial dysfunc-
tion could lead to the development of laminitis in some animals due 
to selective venoconstriction. They assumed that dysfunctional en-
dothelium impairs the vasodilatory action of the important vasodi-
latory neuropeptides P and calcitonin gene-related peptide (CGRP) 
that are stored in endothelial cells. Consequently, the digital blood 
vessels failed to relax adequately to maintain normal vascular blood 
flow (Katz & Bailey, 2012). Moreover, according to Katz, Marr, and 
Elliott (2011) equine digital arteries relax more than the digital veins 
in response to CGRP and that even in the absence of the endothe-
lium, the relaxant effect of CGRP on blood vessels was still evident.
Recently, the establishment of a pro-angiogenic environment 
became a novel therapeutic target in the treatment of laminitis. 
Angelone et al. (2017) described application of adipose tissue-de-
rived MSCs in the therapy of equine laminitis. An experimental 
protocol based on the local intravenous administration of adipose 
tissue-derived MSCs in combination with platelet-rich plasma was 
developed for the treatment of horses affected by chronic laminitis. 
In the long term, the venograms showed a progressive amelioration 
of the vascularization of the foot, which led to an improvement in 
the structure and function of the hoof and thus greatly enhanced 
the quality of life of all treated horses. Angelone et al. (2017) pro-
posed that both adipose tissue-derived MSCs and PRP could have 
the potential to contribute to restore a functional vascular network 
by controlling inflammation, recruiting local cells to restore tissue, 
lowering ROS and MMP damage, stabilizing vascular walls and pro-
moting neoangiogenesis. The results of Angelone et al. (2017) should 
be treated with caution, since the study was restricted to only nine 
horses, which were previously unsuccessfully treated with conven-
tional therapies. Also, there was no control group. Further investiga-
tions are needed to clarify the possible role of regenerative therapies 
including the establishment of a pro-angiogenic environment in the 
treatment of chronic laminitis.
6  | PERSPEC TIVE
It has become evident that excessive, deficient or dysfunctional an-
giogenesis contributes to the pathogenesis of many equine disor-
ders. To create a solid foundation for future research towards new 
therapeutic angiogenesis-related strategies for horses, many parts 
of the puzzle are still missing.
Relatively little ongoing research is concerned with the impor-
tance of endothelial progenitor cells for horses and with pro- and 
anti-angiogenic treatments with endothelial regulatory molecules for 
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pathological conditions such as tumours, eye diseases, wound healing 
disorders, musculoskeletal system diseases or laminitis. In addition, 
the published results are unfortunately fragmentary and sometimes 
even contradictory and raise more questions than they answer. For 
example, the specific role of the capillary bed in diseases like equine 
laminitis remains unexplained (Morgan et al., 2018; Morgan, Keen, 
Walker, & Hadoke, 2016). Vascular endothelial cells may be a target 
for the diagnosis or therapy of laminitis and other diseases.
Another interesting topic could be the role of pericytes in an-
giogenesis and their potential in regenerative medicine in different 
species including the horse. An exciting review has been published 
recently by Esteves and Donadeu (2018).
The jugular vein in horses is very sensitive to mechanical or 
chemical lesions. Intravenous injections frequently result in throm-
bophlebitis, which often has fatal consequences (Dias & Neto, 2013). 
One potential cause for this could be endothelial dysfunction, since 
activated endothelial cells have an important role in the pathogen-
esis of thrombosis (Poredos & Jezovnik, 2018). Moreover, dysfunc-
tional angiogenesis is known to result in ineffective thrombolysis 
(Alias et al., 2014).
In order to learn more about the huge population of heteroge-
neous endothelial cells, a potential future focus may be the inves-
tigation of interendothelial communication. In the last decade, a 
new way of intercellular communication came into the focus of re-
search, involving extracellular vesicles like exosomes and ectosomes 
(Meldolesi, 2018). First studies revealed that membrane vesicles 
produced by equine mesenchymal stem cells are involved in intercel-
lular communication with endothelial cells, stimulating angiogenesis 
in the horse (Pascucci et al., 2014).
The challenge for the future is to continue research into the in-
volvement of disproportionate angiogenesis in horse diseases. There 
is also a need to describe the molecular basis of angiogenesis-asso-
ciated horse diseases in a more detailed and integrative manner so 
that the results of science can be better transferred to the develop-
ment of new therapeutic treatments.
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